Home › Interstitial Lung Diseases › Oregon
Interstitial Lung Diseases clinical trials in Oregon
8 studies for Interstitial Lung Diseases are looking for participants at sites in Oregon.
Cities in Oregon
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Oregon Clinic, Portland
RecruitingObservational study
Ages 21 and older · All sexes · Updated Nov 12, 2026 · NCT01915511An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA003, Bend
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07234032Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA003, Bend
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07179380A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Summit Health, Bend
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 14, 2026 · NCT07285655A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Bend Memorial Clinic, Bend
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Oct 8, 2026 · NCT07175038A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Bend
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 11, 2026 · NCT07816185DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Summit Health, Bend
- Legacy Research Institute, Portland
- Oregon Health & Science University, Portland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Oregon Health & Science University (OHSU), Portland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.